Eric Lefkofsky founded Tempus AI in January 2015, bringing a track record as a serial entrepreneur who had previously co-founded Groupon, Echo Global Logistics, InnerWorkings, and Mediaocean. As CEO, Lefkofsky has directed Tempus's growth as a precision-medicine company applying AI to genomic and clinical data specifically within oncology and cardiology.
Lefkofsky led Tempus through its June 2024 initial public offering on the Nasdaq, and has continued to position the company's AI-driven approach to personalized treatment selection as central to its long-term strategy in healthcare AI.